Special articleEvaluation of monoclonal antibodies having specificity for human IgG sub-classes: Results of an IUIS/WHO collaborative study
References (21)
- et al.
Immunol. Today
(1984) - et al.
Immunology
(1982) - et al.
- et al.
Immunology
(1982) - et al.
Immunology
(1974) - et al.
Adv. Immunol.
(1972) Adv. Immunol.
(1974)- et al.
Ric. Clin. Lab.
(1980)et al.Ric. Clin. Lab.
(1980) - et al.
J. Exp. Med.
(1968) - et al.
Nature (London)
(1975)
Cited by (329)
Immunofluorescence Staining for IgG Subclass: Cause for Discrepancy in the Detection of IgG1
2023, Kidney International ReportsSelection and validation of antibody clones against IgG and IgA subclasses in switched memory B-cells and plasma cells
2019, Journal of Immunological MethodsCitation Excerpt :In turn, IgG3 and IgA1 show elongated hinge domains that have an impact on the orientation of the V domains, and confer a higher susceptibility to proteases, compared to other Ig subclasses of the same isotype (Schroeder and Cavacini, 2010; Vidarsson et al., 2014). In line with this, most epitopes targeted by the Ab clones that showed strong reactivity on human B-cells and PCs in our study, had been previously mapped in the CH2 and the hinge domains (Hamilton and Morrison, 1993; Harada et al., 1991; Jefferis et al., 1992, 1985; Lighaam et al., 2014; Mestecky et al., 1996; Reimer et al., 1989, 1984). In contrast, all Ab clones targeting the CH3 Igγ-heavy chain region, such as the HP6011, HP6023, HP6025 and HP6206 Ab clones (Hamilton and Morrison, 1993; Jefferis et al., 1992, 1985; Lighaam et al., 2014) systematically failed to show a specific, reproducible and robust staining profile on human B-cells and PCs.
Peptide Antibodies in Clinical Laboratory Diagnostics
2017, Advances in Clinical ChemistryPhenotypic differences between IgG<inf>4</inf><sup>+</sup> and IgG <inf>1</inf><sup>+</sup> B cells point to distinct regulation of the IgG <inf>4</inf> response
2014, Journal of Allergy and Clinical ImmunologyClinical laboratory assessment of immediate-type hypersensitivity
2010, Journal of Allergy and Clinical ImmunologyCitation Excerpt :Historically, IgG4 reaginic antibodies were believed to be diagnostic because monoclonal anti-human IgG4 could induce BHR from allergic donors cells.48 In 1992, this issue was challenged by Lichtenstein et al,49 who showed no histamine release (<10%) was detected from nonatopic donor cells after incubation with a panel of highly specific International Union of Immunological Societies–documented human IgG subclass–specific mAbs.50 Moreover, 85% of these same cells released to anti-IgE.
- ∗
For full addresses see Appendices I and II.